Featured Research

from universities, journals, and other organizations

Study Shows Unrelated Marrow Transplantation Offers Hope Of Cure For People Diagnosed With Chronic Myeloid Leukemia

Date:
April 7, 1998
Source:
Fred Hutchinson Cancer Research Center
Summary:
A new study demonstrates that marrow transplantation using HLA-matched unrelated donors can be safe and effective therapy for patients with chronic myeloid leukemia (CML) in chronic phase. Seattle researchers also believe that transplantation should not be limited to younger people, under the age of 40 years.

Fred Hutchinson Cancer Research Center Study Finds Survival Rates are Comparable to HLA-Matched Sibling Donors When Treated Under Outlined Optimal Conditions

Seattle - A new study demonstrates that marrow transplantation using HLA-matched unrelated donors can be safe and effective therapy for patients with chronic myeloid leukemia (CML) in chronic phase. Seattle researchers also believe that transplantation should not be limited to younger people, under the age of 40 years. Fred Hutchinson Cancer Research Center researchers published the results of their study in the April 2, 1998, issue of The New England Journal of Medicine.

Transplantation has been shown to be the cure for many blood disorders and inherited diseases, including CML. One obstacle has always been the identification of a suitably matched donor. Previously, it was believed that only those CML patients with an HLA-matched sibling donor had an option for curative treatment. This study concludes that marrow transplantation from an HLA-matched unrelated donor can be the treatment of choice for many CML patients and should be considered early in the course of disease to optimize outcome. According to researchers, this study showed that people diagnosed with CML who undergo an unrelated HLA-matched transplant have a comparable rate of survival to those diagnosed with the same disease who undergo an HLA-matched sibling marrow transplant.

The research team, led by John Hansen, M.D., head of Human Immunogenetics at the Fred Hutchinson Cancer Research Center, reviewed the results of 196 patients transplanted with unrelated donor marrow between May 1985 and December 1994. All patients were under 55 years of age and had been diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. The overall survival rate was 57 percent, but for patients less than 50 years old transplanted from an HLA matched donor within one year from diagnosis the survival rate was 74 percent. The overall survival rate for similar patients who have undergone transplant with a matched sibling donor is 77 percent. The factors associated with a better survival following an unrelated donor transplant included transplantation within the first year of diagnosis, selection of an HLA-matched donor and post-transplant supportive care aimed at protecting patients from viral and fungal infections.

"These conditions offer the best chance for survival, says Hansen. "The time factor underscores the importance of planning treatment early and performing an HLA family study to determine if the patient has an HLA-matched related donor. If an HLA-matched donor cannot be found within the family, an unrelated donor search should be started."

According to the analysis, graft-versus-host disease (GVHD) still is an issue for patients receiving an unrelated donor transplant, especially if HLA matching is not complete. Researchers believe that GVHD can be minimized in male patients by the use of an HLA-matched male donor, and the risk of chronic GVHD can be minimized in male and female patients by the use of male donors or females who have never given birth.

Previous studies have shown the incidence of graft failure was higher than expected following an unrelated donor transplant for patients with CML. Researchers believe this was a result of undetected HLA incompatibility in the donor. In the current study the marrow was not T-cell depleted (T-cells are the white blood cells that initiate immune responses) and the risk of graft failure was lower than originally anticipated. The patients in this study, however received unmodified marrow grafts replete of donor T cells, whereas the previous studies reporting higher rates of graft failure performed T cell-depletion of donor marrow prior to transplantation.

This study was funded by the National Institutes of Health. The National Marrow Donor Program, and other registries, make it possible for patients to find donors.


Story Source:

The above story is based on materials provided by Fred Hutchinson Cancer Research Center. Note: Materials may be edited for content and length.


Cite This Page:

Fred Hutchinson Cancer Research Center. "Study Shows Unrelated Marrow Transplantation Offers Hope Of Cure For People Diagnosed With Chronic Myeloid Leukemia." ScienceDaily. ScienceDaily, 7 April 1998. <www.sciencedaily.com/releases/1998/04/980407074434.htm>.
Fred Hutchinson Cancer Research Center. (1998, April 7). Study Shows Unrelated Marrow Transplantation Offers Hope Of Cure For People Diagnosed With Chronic Myeloid Leukemia. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/1998/04/980407074434.htm
Fred Hutchinson Cancer Research Center. "Study Shows Unrelated Marrow Transplantation Offers Hope Of Cure For People Diagnosed With Chronic Myeloid Leukemia." ScienceDaily. www.sciencedaily.com/releases/1998/04/980407074434.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins